Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 3:21 pm Purchase | 2024-12-31 | 13G | Theratechnologies Inc. THTX | MORGAN STANLEY MS | 2,313,769 5.000% | 2,313,769 (New Position) | Filing History |
| 2025-02-07 4:13 pm Sale | 2025-01-31 | 13G | Applied Therapeutics, Inc. APLT | MORGAN STANLEY MS | 2,858,931 2.500% | -5,956,595 (-67.57%) | Filing History |
| 2025-02-07 12:37 pm Sale | 2024-12-31 | 13G | Envista Holdings Corp NVST | MORGAN STANLEY MS | 14,141,070 8.200% | -1,757,797 (-11.06%) | Filing History |
| 2025-02-06 11:58 am Purchase | 2024-12-31 | 13G | TAL Education Group TAL | MORGAN STANLEY MS | 8,908,863 5.800% | 1,490,971 (+20.10%) | Filing History |
| 2025-02-05 2:09 pm Sale | 2024-12-31 | 13G | Virtus Total Return Fund Inc. ZTR | MORGAN STANLEY MS | 1,671,707 2.700% | -1,768,567 (-51.41%) | Filing History |
| 2025-02-05 2:02 pm Sale | 2024-12-31 | 13G | U.S. Physical Therapy, Inc. USPH | MORGAN STANLEY MS | 889,644 5.900% | -149,773 (-14.41%) | Filing History |
| 2025-02-05 1:51 pm Sale | 2024-12-31 | 13G | Sphere Entertainment Co. SPHR | MORGAN STANLEY MS | 1,270,866 4.400% | -782,116 (-38.10%) | Filing History |
| 2025-02-05 1:44 pm Sale | 2024-12-31 | 13G | Cohen & Steers Real Estate Opportunities Income Fund RLTY | MORGAN STANLEY MS | 679,684 4.100% | -308,903 (-31.25%) | Filing History |
| 2025-02-05 1:06 pm Sale | 2024-12-31 | 13G | Western Asset Inflation-Linked Opportunities & Income Fund WIW | MORGAN STANLEY MS | 2,487,171 4.100% | -2,053,853 (-45.23%) | Filing History |
| 2025-02-05 10:46 am Purchase | 2024-12-31 | 13G | Western Asset Inflation-Linked Opportunities & Income Fund WIW | MORGAN STANLEY MS | 4,541,024 7.400% | 182,866 (+4.20%) | Filing History |
| 2025-02-05 10:43 am Purchase | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | MORGAN STANLEY MS | 17,629,264 8.600% | 17,629,264 (New Position) | Filing History |
| 2025-02-05 10:41 am Purchase | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | MORGAN STANLEY MS | 4,542,992 7.400% | 4,542,992 (New Position) | Filing History |
| 2025-02-05 10:38 am Sale | 2024-12-31 | 13G | Brookfield Real Assets Income Fund Inc. RA | MORGAN STANLEY MS | 2,455,074 4.400% | -1,268,631 (-34.07%) | Filing History |
| 2025-02-05 10:23 am Purchase | 2024-12-31 | 13G | Western Asset Premier Bond Fund WEA | MORGAN STANLEY MS | 1,538,313 13.000% | 133,391 (+9.49%) | Filing History |
| 2025-02-05 10:10 am Purchase | 2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | MORGAN STANLEY MS | 1,157,140 6.200% | 1,157,140 (New Position) | Filing History |
| 2025-02-05 10:09 am Sale | 2024-12-31 | 13G | UroGen Pharma Ltd. URGN | MORGAN STANLEY MS | 752,861 1.800% | -1,419,466 (-65.34%) | Filing History |
| 2025-02-05 10:07 am Purchase | 2024-12-31 | 13G | Galaxy Next Generation, Inc. GAXYQ | MORGAN STANLEY MS | 4,836,001 6.900% | 4,836,001 (New Position) | Filing History |
| 2025-02-05 10:05 am Purchase | 2024-12-31 | 13G | Tortoise Energy Infrastructure Corporation TYG | MORGAN STANLEY MS | 960,816 8.900% | 205,924 (+27.28%) | Filing History |
| 2025-02-05 10:03 am Purchase | 2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | MORGAN STANLEY MS | 5,362,169 6.300% | 5,362,169 (New Position) | Filing History |
| 2025-02-05 10:01 am Purchase | 2024-12-31 | 13G | ATRenew Inc. RERE | MORGAN STANLEY MS | 4,890,678 5.600% | 4,890,678 (New Position) | Filing History |